Anterior transmural myocardial infarction: Controlled randomized studies  by Spodick, David H.
1240 LETTERS TO THE EDITOR JACC Vol 2, No 6
December 1983 1237-41
of small vessel spasm. We also believe that although spasm of
resistance vessels may. in certain instances, contribute to the extent
of ischemic injury occurring in patients with coronary artery dis-
ease experiencing an acute infarction, the evidence is overwhelm-
ing that large vessel obstruction is of paramount importance. Thus,
while our study does suggest an important independent role of
myocardial resistance vessels in the cause of myocardial ischemia
and infarction, it does not directly support Hellstrom's interesting
but highly speculative hypothesis.
II
Zoneraich raises the possibility of morphologically abnormal
arteriolar vessels, as has been described in some, but not all,
patients with diabetes mellitus (4,5). The three diabetic patients
in our series demonstrated a broad spectrum of coronary flow
responses. One patient (Patient 16) demonstrated significant in-
creases in coronary flow without chest pain in the control, cold
pressor and ergonovine studies with simultaneous pacing. Patient
17, although demonstrating a normal flow response during the
control pacing and cold pressor test studies, was found to have
limited vasodilator reserve associated with chest pain and de-
creased lactate consumption during the ergonovine study. Patient
8 demonstrated limited vasodilator reserve, decreased lactate con-
sumption and chest pain during the control and cold pressor test
studies. No other patient in the study demonstrated an elevated
fasting blood sugar. Thus, no obvious association between ab-
normal vasodilator reserve and diabetes mellitus can be made from
this small group.
However, the absence of myocardial biopsy information con-
cerning small vessel pathology makes further discussion about the
role of fixed small vessel disease speculative only. Two points
deserve mention. Another study (6) of patients with chest pain and
"normal" coronary arteries in which myocardial biopsies were
performed reported no small vessel morphologic abnormalities.
Second, fixed small vessel disease in our study would not explain
the dynamic features of the coronary flow responses, that is, in-
appropriate vasodilator reserve or active vasoconstriction un-
masked or exacerbated by vasoconstrictor stimuli. The two hy-
potheses of small vessel disease (fixed versus dynamic) may not
be mutually exclusive. Some diabetic patients may have elements
of both phenomena.
III
Although we have considered all of Cohn's comments, we
have, with great forbearance, limited our response to his questions
regarding the science of our study. Cohn expresses concern about
the absence of true control subjects in our study (that is, healthy
subjects not complaining of chest pain). Ethical considerations
prohibit participation of such a population in an extensive invasive
study that carries a risk of morbidity and mortality, albeit small.
Nonetheless. patients experiencing their typical chest pain during
this study clearly differed in their coronary circulatory response
to pacing and vasoconstrictor stimuli from those patients not ex-
periencing pain during the study. We believe the patients not
experiencing pain can be considered a reasonable control group.
Although the number of patients may seem small to Cohn, the
demonstration of limited vasodilator reserve, especially when, after
ergonovine. there is essentially no overlap of data, was impressive.
We have now studied over 50 patients using the same protocol,
and the same observations made in our initial study have been
noted in this larger group. The hypothesis of abnormal vasodilator
reserve of small coronary arteries, presumably arterioles, is rea-
sonably supported by the data, and has been suggested by others
(6). Our study shows that this abnormality is dynamic and may
be unmasked or exacerbated by vasoconstrictor stimuli. That our
findings are biologically significant is strongly suggested by the
observation that vasoconstnctor stimuli not only produce the pa-
tient's typical chest pain, but that the pain is associated with lim-
ttation of coronary blood flow and abnormal lactate metabolism,
Cohn, in his remarks, Implies the obvious: that studies should
not be published until they satisfy the criteria established for good
science. The perception of what these criteria are may vary from
one scientist to another, and we cannot bear responsibility for other
studies on atypical chest pain to which Cohn refers and which
have not withstood the test of time. However. it is our opinion
(and that of two reviewers, the editors of lACC and the authors
of an editorial accompanying our study) that our findings are im-
portant and merit publication.
More studies are clearly needed to clarify the mechanism of
angina in these patients. For the present, "small vessel spasm"
and" inappropriate small vessel vasodilator reserve" must be con-
sidered tentative hypotheses. We hope our work will stimulate
further investigation in this possibly common and important man-
ifestation of angina pectoris.
RICHARD O. CANNON. III, MD
STEPHEN E. EPSTEIN. MD, FACC





Hellstrom HR The Injury-spasm (Ischemia-induced hemostatic vasoconstncnve)
and vascular autoregulatory hypothesis of ischemic disease Am J Cardiol
1982049 802-10.
2 Berne RM. RubIO R. Coronary circulation In Berne RM. Sperelakis N. Geiger
SE. eds Handbook of Physiology The Cardiovascular System Baltimore: WII-
hams & Wilkins. 1979 873-952
Masen A, Seven S, DeNes M, et al "Vanant" angina. one aspect of a continuous
spectrum of vasospastic myocardial Ischemia Am J Cardiel 1978:42.1019-33
4 Blumenthal HT, Alex M, Goldenberg S A study of lesions of the Intramural
coronary artery branches In diabetes mellitus Arch Pathol 1960:70 27-42
5 James TN Pathology of small coronary artenes Am J Cardiol 1962,20679-91.
6 Opherk 0, Zebe H, Weihe E, et al Reduced coronary dilatory capacity and
ultrastructural changes of the myocardium In patients With angina pectens but
normal coronary artenograms. Circulanon 1981.63 817-25
Anterior Transmural Myocardial Infarction:
Controlled Randomized Studies
DeWood and colleagues (I) have contributed a technically ex-
cellent, well written and therapeutically promising study of surgical
reperfusion during acute myocardial infarction. While the authors
did not begin scientifically-with an appropriately designed. ran-
domized trial (2)-they have made two separate declarations (both
on page 1232) indicating I) that they understand that uncontrolled,
nonrandomized studies could introduce bias, and 2) that "a con-
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trolled and random trial will be necessary to form firm conclu-
sions." Time would have been saved and the wished for firm
conclusions could be at hand. had the authors begun with a ran-
domized trial (2). Perhaps "better late than never" is what we
may anticipate-if these statements are more than ritualistic adorn-
ments. (Similar calls for appropriate trials. perhaps to achieve
"revision accepted" when the principle may not be accepted. have
become commonplace (3). The authors are the most experienced
people in this promising field and it would be encouraging to hear
from them if they are now. or will be, engaged in a controlled
trial. Indeed. 4 years ago, concluding a 387 patient study ("re-
vision accepted July 16, 1979"), they declared. "Although the
data are promising. a controlled randomized trial will be necessary
to resolve this issue" (4).
I should also like to ask the authors how they determined that
they were dealing with transmural infarctions. I believe a mass
of evidence indicates fairly conclusively that the electrocardiogram
is not an adequate guide to that determination (5,6).
DAVID H. SPOmCK, MD, DSc. FACC
Professor of Medicine
University of Massachusetts Medical School
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Reply
Spodick suggests that there is somehow a link between a call
for controlled randomized trials and the ability to publish in the
Journal of the American College of Cardiology and the American
Journal ofCardiology. Since the articles he references did suggest
it would be helpful to conduct such trials, he implies that perhaps
this was less than a sincere approach to evaluating the problem of
reperfusion in myocardial infarction.
I think it is important to understand clearly that those calls for
randomized trials were sincere. Publication of the articles was not
tied to a requirement that randomization be suggested. The original
drafts contained that concept. In no way did the hope of publication
nor did the referees require a call for randomization between con-
ventional therapy and reperfusion.
More than 2 years ago. our group voted to begin randomized
tnals with reperfusion. The institutional review boards of both
medical centers approved the randomized trials. It has been difficult
to begin these trials, because of difficulty in funding and because
of the position taken by the administrators of both medical centers
that the trials should be totally funded.
We have therefore entered into a difficult situation wherein the
physicians believe that randomization should take place and yet
funding and admmistrative difficulties have hindered progress in
that area. Importantly, we have not found the private practice of
medicine to be an Impediment to the community's acceptance of
randomization. None of our practitioners were threatened by the
possibility of changing referral patterns because of randomization
since the cardiologists and the surgeons in the community who
practice invasive cardiology were supportive of the study.
MARCUS A. DeWOOD. MD
Division of Cardiology
Sacred Heart Medical Center
Deaconess Medical Center
West 800 Fifth Avenue
Spokane. Washington 99210
Correction
In the article, "Noninvasive Evaluation of Normal
and Abnormal Prosthetic Valve Function" by Kotler et al.
(J Am Coll Cardiol 1983;2:151-73), Figure 4 on page 157
was published incorrectly. The schematic diagrams of the
phonoechocardiograms in this figure were reversed. The
diagram at the top should have appeared at the bottom, and
that at the bottom at the top.
